Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.

SARS-CoV-2 variants effective reproductive number international contest phylodynamic

Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
11 2023
Historique:
revised: 11 10 2023
received: 13 07 2023
accepted: 12 10 2023
medline: 7 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: ppublish

Résumé

Since the beginning of the pandemic, SARS-CoV-2 has shown a great genomic variability, resulting in the continuous emergence of new variants that has made their global monitoring and study a priority. This work aimed to study the genomic heterogeneity, the temporal origin, the rate of viral evolution and the population dynamics of the main circulating variants (20E.EU1, Alpha and Delta) in Italy, in August 2020-January 2022 period. For phylogenetic analyses, three datasets were set up, each for a different main lineage/variant circulating in Italy in that time including other Italian and International sequences of the same lineage/variant, available in GISAID sampled in the same times. The international dataset showed 26 (23% Italians, 23% singleton, 54% mixed), 40 (60% mixed, 37.5% Italians, 1 singleton) and 42 (85.7% mixed, 9.5% singleton, 4.8% Italians) clusters with at least one Italian sequence, in 20E.EU1  clade, Alpha and Delta variants, respectively. The estimation of tMRCAs in the Italian clusters (including >70% of genomes from Italy) showed that in all the lineage/variant, the earliest clusters were the largest in size and the most persistent in time and frequently mixed. Isolates from the major Italian Islands tended to segregate in clusters more frequently than those from other part of Italy. The study of infection dynamics showed a positive correlation between the trend in the effective number of infections estimated by BSP model and the R

Identifiants

pubmed: 37927140
doi: 10.1002/jmv.29193
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29193

Informations de copyright

© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84:9733-9748.
Worobey M, Pekar J, Larsen BB, et al. The emergence of SARS-CoV-2 in Europe and North America. Science. 2020;370:564-570.
Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Nat Acad Sci. 2020;117:9241-9243.
Balloux F, Tan C, Swadling L, et al. The past, current and future epidemiological dynamic of SARS-CoV- 2. Oxford Open immunol. 2022;3:iqac003.
Alicandro G, Remuzzi G, La Vecchia C. COVID-19 pandemic and total mortality in the first six months of 2020 in Italy. Med Lav. 2020;111:351-353.
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? The Lancet. 2020;395:1225-1228.
Usuelli M. The Lombardy region of Italy launches the first investigative COVID-19 commission. The Lancet. 2020;396:e86-e87.
Alteri C, Cento V, Piralla A, et al. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy. Nat Commun. 2021;12:434.
Stefanelli P, Faggioni G, Lo Presti A, et al. Whole genome and phylogenetic analysis of two SARS-CoV- 2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Euro Surveill. 2020;25:2000305.
Lai A, Bergna A, Toppo S, et al. Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020. Sci Rep. 2022;12:5736.
Lai A, Bergna A, Caucci S, et al. Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic. Viruses. 2020;12:798.
Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812-827.e19.
Hodcroft EB, Zuber M, Nadeau S, et al Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595:707-712.
Lai A, Bergna A, Menzo S, et al. Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. Virol J. 2021;18:168.
Lai A, Bergna A, Della Ventura C, et al. Epidemiological and clinical features of SARS-CoV-2 variants circulating between April-December 2021 in Italy. Viruses. 2022;14:2508.
Focosi D, Maggi F, McConnell S, Casadevall A. Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic. Future Microbiol. 2022;17:219-221.
Billah MA, Miah MM, Khan MN. Reproductive number of coronavirus: a systematic review and meta- analysis based on global level evidence. PLoS One. 2020;15:e0242128.
Adam DC, Wu P, Wong JY, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nature Med. 2020;26:1714-1719.
Grubaugh ND, Ladner JT, Lemey P, et al. Tracking virus outbreaks in the twenty-first century. Nat Microbiol. 2019;4:10-19.
Rife BD, Mavian C, Chen X, et al. Phylodynamic applications in 21(st) century global infectious disease research. Glob Health Res Policy. 2017;2:13.
Attwood SW, Hill SC, Aanensen DM, Connor TR, Pybus OG. Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic. Nat Rev Genet. 2022;23:547-562.
Minh BQ, Schmidt HA, Chernomor O, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the Genomic Era. Mol Biol Evol. 2020;37:1530-1534.
Bouckaert R, Vaughan TG, Barido-Sottani J, et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2019;15:e1006650.
Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior summarization in Bayesian phylogenetics using tracer 1.7. Syst Biol. 2018;67:901-904.
Stadler T, Kühnert D, Bonhoeffer S, Drummond AJ. Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV). Proceedings of the National Academy of Sciences. 2013;110:228-233.
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia. N Engl J Med. 2020;382:1199-1207.
Walker PR, Pybus OG, Rambaut A, Holmes EC. Comparative population dynamics of HIV-1 subtypes B and C: subtype-specific differences in patterns of epidemic growth. Infect Genet Evol. 2005;5:199-208.
Manathunga SS, Abeyagunawardena IA, Dharmaratne SD. A comparison of transmissibility of SARS- CoV-2 variants of concern. Virol J. 2023;20:59.
Suzuki R, Yamasoba D, Kimura I, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 omicron variant. Nature. 2022;603:700-705.

Auteurs

Annalisa Bergna (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Alessia Lai (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Carla Della Ventura (CD)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Bianca Bruzzone (B)

Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy.

Alessandro Weisz (A)

Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno and Genome Research Center for Health, Baronissi, Italy.

Morena d'Avenia (M)

UOSVD of Cytopathology and Screening, Department of Laboratory Medicines, Ospedale di Venere, Asl Bari, Bari, Italy.

Sophie Testa (S)

Unit of Infectious Diseases, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy.

Carlo Torti (C)

Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.

Caterina Sagnelli (C)

Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Angela Menchise (A)

Microbiology and Virology Laboratory, A.O.R. San Carlo Potenza, Potenza, Italy.

Gaetano Brindicci (G)

Infectious Diseases Unit, University of Bari, Bari, Italy.

Daniela Francisci (D)

Department of Medicine and Surgery, Clinic of Infectious Diseases, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Ilaria Vicenti (I)

Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Nicola Clementi (N)

Laboratory of Microbiology and Virology, Università "Vita-Salute" San Raffaele, Milan, Italy.
Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Annapaola Callegaro (A)

Ospedali Riuniti, Department of Infectious Diseases, Bergamo, Italy.

Emmanuele Venanzi Rullo (EV)

Unit of Infectious Diseases, Department of Experimental and Clinical Medicine, University of Messina, Messina, Italy.

Sara Caucci (S)

Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche, Ancona, Italy.

Vanessa De Pace (V)

Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy.

Andrea Orsi (A)

Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy.
Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.

Stefano Brusa (S)

Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Francesca Greco (F)

UOC Microbiology and Virology, PO Cosenza, Cosenza, Italy.

Vittoria Letizia (V)

UOSD Genetic and Molecular Biology, AORN Sant'Anna and San Sebastiano di Caserta, Caserta, Italy.

Emilia Vaccaro (E)

Molecular Biology Units, AOU 'S. Giovanni di Dio e Ruggi d'Aragona' Università di Salerno, Salerno, Italy.

Gianluigi Franci (G)

Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno and Genome Research Center for Health, Baronissi, Italy.

Francesca Rizzo (F)

Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno and Genome Research Center for Health, Baronissi, Italy.

Fabio Sagradi (F)

Unit of Infectious Diseases, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy.

Leonardo Lanfranchi (L)

Unit of Infectious Diseases, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy.

Nicola Coppola (N)

Department of Mental Health and Public Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Annalisa Saracino (A)

Infectious Diseases Unit, University of Bari, Bari, Italy.

Michela Sampaolo (M)

Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Silvia Ronchiadin (S)

Artificial Intelligence Laboratory, Intesa Sanpaolo Innovation Center, Turin, Italy.

Massimo Galli (M)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Agostino Riva (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Gianguglielmo Zehender (G)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH